Medtech Week Recap: Bone Developed from Human Embryonic Stem Cells Could Have Therapeutic ApplicationsMay 21, 2012 – 12:52 am
Researchers have grown bone from human embryonic stem cells. The research could have applications in therapies to replace bone tissue.
Scientists Grow Bone from Human Embryonic Stem Cells (OrthoTec)
The effort by hospitals to phase out PVC in IV bags and tubing is a waste of resources and energy, says Len Czuba, President of Czuba Enterprises Inc. and former president of the Society of Plastics Engineers.
Sounding off on PVC bans, biomaterials’ pricing and antimicrobials (PlasticsToday)
AlpVision and Nolato Medical have announced a new partnership to protect pharmaceuticals and medical devices from counterfeiting.
Nolato Medical and AlpVision Announce Joint Collaboration to Protect Pharmaceutical Primary Packaging and Medical Devices (PMPNews)
Last week, an associate professor of Harvard School of Public Health announced his decision to resign as an associate editor of Genomics, because he thinks the system “provides solid profits for the publisher while effectively denying colleagues in developing countries access to research findings.” The announcement is the latest development in the Academic Spring movement.
I can no longer work for a system that puts profit over access to research (The Guardian)
Recently, hospitals group asked IRS to make sure that medical device makers don’t raise prices to cover the cost of the 2.3% tax on revenue that will start in 2013. This is a “manufactured issue” and makes no sense, says the Medical Imaging & Technology Alliance.
MITA: Windfall rhetoric about med-tech tax makes no sense at all (MassDevice)